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ABSTRACT 
Background 
An area of care in which nurses, caring for people with diabetes are involved, is the 
management of medications. Although appropriately qualified nurses in the United 
Kingdom have virtually the same prescribing rights as doctors, there is little or no 
evidence examining the prescription of medicines by nurses for these patients.   
Aim 
To examine Nurse Independent/Nurse Supplementary Prescribing for people with 
diabetes and the extent to which these nurses feel prepared for this role. 
 Methods 
The Nursing and Midwifery Council database was used to select a random sample of 
1992 registered Nurse Independent/Nurse Supplementary Prescribers. Of these, 1400 
questionnaires were returned. Medicines for people with diabetes were prescribed by 
439 respondents. This paper reports on the findings of these 439 nurses.  
Results 
Four hundred and nine (95.1%) participants used independent prescribing and 214 
(49.8%) used supplementary prescribing. The majority of respondents were highly 
experienced and worked in primary care. Some nurses (7.6%) reported that the 
prescribing programme did not meet their need. The needs of those nurses who had 
undertaken specialist training in diabetes were met to a statistically significantly 
greater extent than those without this training.  Nurse prescribing is viewed positively 
by nurses prescribing for people with diabetes. 
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Conclusion 
Although nurse prescribing has effectively increased patient choice with regards to 
accessing medicines for diabetes, approximately 50% of the nurses in this study 
reported that the prescribing programme did not meet their needs for this role. The 
needs of nurses with specialist training in diabetes were met to a greater extent than 
those without this training. Twenty percent of the nurses in this study did not have this 
training.  The educational preparation for nurses adopting the role of prescriber for 
people with diabetes requires further exploration.   
 
 Key Words: Questionnaire survey, nurse prescribing, diabetes, Nurse Independent 
Prescribing, Nurse Supplementary Prescribing.  
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SUMMARY 
What is already known about this topic 
 The management of medications is an area of care in which nurses, caring for 
people with diabetes, are involved.   
 Nurses do prescribe medicines for people with diabetes. 
  Some nurses feel ill prepared to prescribe medicines for some conditions with 
regards to pharmacology, physical assessment and diagnosis.  
 
What this paper adds 
 Approximately a third of Nurse Independent/Nurse Supplementary Prescribers 
prescribe medicines for people with diabetes. 
 Over 90% of these nurses use Nurse Independent Prescribing and nearly 50% 
use Nurse Supplementary Prescribing.  
 The Nurse Independent/Nurse Supplementary Prescribing programme does not 
meet the needs of all nurses who prescribe medicines for people with diabetes  
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INTRODUCTION 
Diabetes Mellitus (DM) is one of the most common chronic diseases in both western 
and developing countries. It is estimated that 194 million people worldwide or 5.1% 
of the population currently suffer from this condition (Audit Commission 2000). Five 
million pounds a day is spent by the National Health Service (NHS) on treatment for 
diabetes and much of this could be reduced with good healthcare and good self-
management (Department of Health (DoH) 2003a).  
 
It is evident that nurses working in a variety of roles, with varying levels of expertise, 
are involved in the treatment management of people with diabetes (Carey & 
Courtenay 2007). Furthermore, the National Service Framework (NSF) for Diabetes 
emphasises the role of the nurse in service delivery for people with diabetes and 
prescribing is highlighted as a means of optimising this role (DoH 2003a).  
 
In the United Kingdom (UK), appropriately qualified community nurses are able to 
assess, diagnose and prescribe independently from a limited list of medicines included 
in the Nurse Prescribers’ Formulary (NPF) for Community Practitioners. Nurse 
Independent Prescribers (NIPs) (previously known as independent extended 
prescribers) are similarly able to assess, diagnose and prescribe any licensed medicine 
(and some controlled drugs (CDs)) independently (DoH 2005). By contrast, Nurse 
Supplementary Prescribing (DoH 2003b) takes place after an assessment and 
diagnosis of a patients condition has been made by a doctor, and a Clinical 
Management Plan (CMP) has been drawn up for the patient. The CMP includes a list 
of medicines from which the supplementary prescriber is able to prescribe (DoH 
2003b). Supplementary prescribers are able to prescribe any medicine (including 
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unlicensed medicines and CDs), and this mode of prescribing is best suited to patients 
with long-term chronic conditions.  
 
Training for Nurse Independent and Nurse Supplementary Prescribing is combined 
i.e. nurses successfully completing the prescribing programme are awarded the dual 
qualification of NIP/Nurse Supplementary Prescriber (NSP). This qualification is 
recorded on the Nursing and Midwifery Council (NMC) register (the NMC is the 
UK’s regulatory body for the Nursing, Midwifery and Health Visiting professions). 
Any registered nurse with a minimum of 3 years experience as a qualified nurse, the 
ability to study at degree level, and working in a role in which prescribing would be 
required, is eligible to undertake prescribing training. The programme, validated by 
the NMC, is offered in approximately 60 higher education institutions throughout the 
United Kingdom (UK) and provides students with generic knowledge and skills that 
underpin the principles of prescribing. Topics covered include consultation skills and 
decision making, the legal and ethical aspects of prescribing, and applied 
pharmacology (NMC 2006). It is the responsibility of the nurse prescriber to remain 
up-to-date with the knowledge and skills necessary to be able to prescribe 
competently and safely (NMC 2006). There are now over 10,000 nurses across the 
UK able to prescribe both as NIPs and NSPs (NMC 2007) 
 
Prescriptive authority for nurses has moved forward significantly in other countries. 
However, this authority has come about for a number of different reasons (David & 
Brown 1995, Cornwall & Chiverton 1997, DoH 1999). In Sweden nurse prescribing 
was introduced to provide access to health professionals in remote areas, and reduce 
doctors workload (David and Brown 1995). As of 1994, all district nurses in Sweden 
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have been able to prescribe from a list of over 200 medicines for over 60 conditions 
(Buchan & Calman 2004). Similarly, in rural areas of Australia, where nurses are 
working autonomously, they have the right to administer and supply certain medicines 
without consulting a doctor. In some parts of Australia, Nurse Practitioners are able to 
prescribe from very limited formularies (McCann & Baker 2002). By contrast, 
prescribing in New Zealand and the United States of America (USA) is part of 
advanced nursing practice. Nurses in New Zealand working in the areas of aged care 
and child/family care are those currently only able to prescribe from a schedule of 
approved medicines (Manchester 2000). In the USA, prescribing has developed 
alongside the role of the Advanced Practice Registered Nurse (APRN). APRN’s are 
the only nurses able to prescribe in the USA. However, unlike the UK, policy and 
practices differ across each State. Very little research has attempted to evaluate nurse 
prescribing in these countries, although it is evident that APRNs who prescribe 
medicines improve patient outcomes and reduced healthcare costs (Brooten et al. 
2002). 
 
Given that nurses in the UK now have virtually the same prescribing rights as doctors, 
it is important to evaluate the early experiences of the process. There is very little or 
no evidence on the prescription of medicines by nurses for people with diabetes and 
whether nurses feel prepared for this role.  
 
BACKGROUND 
Three studies (Winocour et al. 2002, Peters et al. 2001, Craddock & Avery 1998) 
provide evidence that one of the areas of care in which nurses, caring for people with 
diabetes are involved, is the management of medications. Winocour et al. (2002) 
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surveyed 456 consultant physicians providing diabetes services across 238 acute NHS 
trusts and units.  Information collected from 75% of the sample indicated that 
Diabetes Specialist Nurses (DSNs) were involved in the management of medications.   
 
Specifically looking at the role DSNs play with regards to the practice of prescribing 
and adjusting insulin dose, Craddock and Avery (1998) distributed surveys in 1993 & 
1996 to 50 DSNs, in the South West Thames Region.  Of the 71 questionnaires 
distributed across the two surveys, over 70% of the nurses responded. Nurses 
completing the questionnaires in 1996 reported that they were less likely to consult 
doctors when changing the dose of insulin or changing the insulin regime. However, 
they were more likely to have agreed with the doctor the extent to which insulin dose 
could be altered. Additionally, participants in 1996 were more likely to adjust insulin 
dose over the telephone, dispense insulin from an agreed stock, use pre-signed 
prescriptions or supply patients with prescriptions with medical countersignatures. 
 
Also examining the areas of care in which DSNs are involved, Peters et al. (2001) 
used a two-round Delphi technique to assess the opinions of a random stratified 
sample of 160 practice nurses (with a substantial role in the management of diabetes), 
and a random one-third sample of  DSN (255 from 765 names). The resultant sample 
of participants in the first round comprised of 97 practice nurses and 69 DSN’s (with a 
second round response rate of 90 and 59 respectively). It was evident from the 
findings that the DSNs’ strongly supported the prescription of medicines by nurses 
and were of the belief, that the opportunity to prescribe would have significant 
implications with regards to the contribution they would be able to make to the care of 
patients in the community with Type 2 diabetes. 
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Although not specifically focusing on diabetes, Courtenay et al. (2006a) undertook a 
national survey to provide a national perspective of independent 
extended/supplementary nurse prescribing practice. Respondents in this survey 
(n=868) were asked to identify the conditions for which they prescribed most 
frequently using supplementary prescribing. Diabetes was one of the most common 
conditions cited.   
 
Although nurses’ evaluations of nurse prescribing have generally been positive, there 
have been some concerns about nurses’ pharmacological knowledge base, physical 
assessment and diagnostic skills. Lewis-Evans and Jester (2004) used in-depth, 
minimally structured interviews, in an attempt to gain an understanding and insight 
into the experiences of district nurse (DN) and health visitor (HV) prescribers. 
Commenting on the prescribing programme, pharmacology and information about 
treatments prescribed, was one area in which respondents reported that the prescribing 
programme did not adequately meet their needs.  
 
These findings are supported by Latter et al. (2005). Pharmacology, and training in 
physical assessment and diagnosis, were areas in which the 246 independent extended 
nurse prescribers surveyed by these researchers reported the prescribing programme 
to be weak. However, by contrast, 638 independent extended/supplementary 
prescribers surveyed by Courtenay et al. (2006b), and commenting specifically on the 
prescription of medicines for skin conditions, reported that they were generally 
positive about their clinical knowledge, knowledge of pharmacology, assessment and 
diagnostic skills, and treatments options.  
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It is evident from the literature that nurses are involved in the prescription of 
medicines for people with diabetes. Although not specifically focusing on diabetes, 
there is some evidence that pharmacology, physical assessment and diagnosis are 
areas in which some nurses feel ill-prepared for the role of prescriber. However, this 
evidence has been derived from the prescription of medicines by HVs and DNs and 
early independent extended nurse prescribers. There is no research available that has 
looked at Nurse Independent/Nurse Supplementary Prescribing for people with 
diabetes or, how prepared nurses feel for this role. This is important given that 
evidence to date (Courtenay et al. 2006a) has shown that diabetes is one of the most 
common conditions for which supplementary prescribing is used by nurses.  
 
 
THE STUDY 
Aim 
To examine Nurse Independent/Nurse Supplementary Prescribing for people with 
diabetes and the extent to which these nurses feel prepared for this role. 
Design 
A survey design was used, with a postal questionnaire. The data were collected 
between October and December 2006. 
 
Participants 
The participants were 439 nurses located throughout England. All nurses were 
qualified NIPs/NSPs and registered on the NMC data base. All reported that they  
prescribed medicines for people with diabetes.   
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Reliability and Validity 
A questionnaire booklet was developed for the purpose of the study. Its content was 
developed from previous work involving independent extended and supplementary 
nurse prescribers (Latter et al. 2005, Courtenay  et al. 2006a) and a search of the 
literature of nurse-led care in diabetes (Carey & Courtenay 2007). In order to pilot the 
questionnaire 20 qualified NIPs/NSPs who prescribed for diabetic patients were asked 
to complete it. After doing so, they were asked to comment on its ease of completion, 
and if they experienced any difficulties understanding what was required of them at 
any point throughout the questionnaire. It was evident from the completed 
questionnaires that both the format and content of the questions were appropriate. 
Only minor refinements and amendments were made. For example, where 
respondents were asked to comment on the length of time they had been qualified as a 
prescriber, response boxes were made clearer. Following data entry of the completed 
questionnaires by a researcher, ten percent of these questionnaires were then reviewed 
by one of the authors (NC). There was agreement between the data that had been 
entered by the researcher and NC. 
 
Questionnaire 
Simple instructions with regards to how to complete the questions were provided on 
the first page of the booklet. The first section of the questionnaire collected some 
general demographic information. This included job title, participants Grade/Band 
(i.e. level of clinical expertise and the Band/Grade in which an individual is placed 
and for which they are paid. Band 5/Grade E lower band, Band 9/Grade I higher 
band), whether they worked full time or part time, if they worked in primary and/or 
secondary care, their age, and highest academic qualification. The sample were then 
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asked to identify the length of time they had been qualified as a NIP/NSP, how much 
experience they had acquired in their main area of practice before undertaking the 
prescribing programme, and whether they had undertaking any specialist training in 
diabetes prior to undertaking the prescribing programme i.e. diploma, first degree, or 
master's level module in diabetes, accredited study days or, any other training. 
Respondents were then asked to indicate the methods they had used to deliver 
medicines to patients since they had qualified as a prescriber, and the extent to which 
the prescribing programme and the 12 days learning in practice with a designated 
medical practitioner had met their needs with regards to the principles necessary for 
prescribing for people with diabetes. This was assessed by six point Likert scales with 
response options ranging from (1) ‘did not meet my needs’ to (6) ‘completely met my 
needs’.  
 
A further question asked respondents whether they spent some of the 12 days learning 
in practice with another qualified NIP/NSP. The final four questions asked 
participants whether they believed that the NIP/NSP qualification had improved the 
quality of care they were able to offer patients, if they thought it enabled diabetic 
patients to access their medicines faster, if it ensured better use of their skills,   and 
improved job satisfaction. These were each assessed using six point Likert scales 
ranging from ‘strongly disagree’ (1) to ‘strongly agree’ (6).  
 
 
Data collection  
One thousand nine hundred and ninety two nurses were selected at random from all 
(n=7968) nurses registered on the NMC database of NIPs/NSPs i.e. 25% of all 
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NIPs/NSPs across the UK. Based on the findings and response rates of previous 
national surveys undertaken by researcher (Courtenay et al. 2007, Latter et al 2005), it 
was estimated that a 70% response rate would be achieved of whom 30% of 
respondents would prescribe medicines for people with diabetes.  This would yield a 
sample of approx 400 nurses. This large sample was required to ensure that each one 
of the broad range of settings in which nurses prescribe medicines for people with 
diabetes was represented.  
 
Participants were sent a letter outlining the purpose of the study, an information sheet, 
and a copy of the questionnaire. The information sheet outlined the study aims, and 
what participants would be required to do. It also informed participants that the study 
was completely voluntary (and emphasised that individuals could withdraw at any 
point if they wished to do so), that responses were strictly confidential, that 
information collected from the questionnaire would be made anonymous, and that no 
identifying information would emanate from the research. After one follow up 
reminder questionnaire, 1400 (70%) questionnaires were returned, of which 1377 
were completed. Twenty three were not completed as participants were no longer 
working in practice or were working abroad. Of the 1377 completed questionnaires, 
439 participants prescribed for diabetic patients. This paper reports on the findings of 
these nurses.  
 
Ethical approval 
A full research proposal was submitted to the Berkshire Research Ethics Committee 
and the University of Reading Ethics Committee. The study met the research 
governance criteria of these committees and approval was therefore granted. 
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Questionnaires were sent to the home address of participants. Return of a completed 
questionnaire was taken as consent to participate.  
  
Data analysis 
SPSS and Microsoft Excel were used for data entry and analysis. Chi Square tests 
were used when testing for association. The value of the prescribing programme in 
meeting nurses’ needs in prescribing for diabetes and the 12 days medical practice 
support received during the prescribing were determined by requesting respondents to 
score, on a 1-6 Likert scale. The results were further examined by dividing the 1-6 
scale into two groups, i.e. those scoring values 1-3 (reflecting a negative view) and 
those scoring values 4-6 (reflecting a positive view).   
 
Further analysis explored whether respondents’ views on prescribing for people with 
diabetes was influenced by their job title, age, academic qualifications, area of work, 
their experience in their main area of practice before undertaking the prescribing 
programme and having specialist training in diabetes.  For this purpose, the three 
scores (each on a 1-6 scale ranging from strongly disagree to strongly agree), 
corresponding to three relevant questions in the survey questionnaire (the quality of 
care they were able to offer patients, if they thought it enabled diabetic patients to 
access their medicines faster, if it ensured better use of their skills), were averaged to 
provide an overall “success” measure.  A general linear modelling procedure was used 
to explore which if any of the factors i.e. specialist knowledge, age, job title, work 
place, grade/band, full or part time, time qualified as a prescriber and years of 
experience in area of practice before undertaking prescribing programme; contributed 
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significantly to explaining the variation in the overall “success” measure. The model 
was then checked using residual analysis. 
 
 
 
RESULTS 
Demographic details 
The demographic data of the sample including job title, grade/band, part/full time 
work, area of work, age, academic qualification, time since qualified as NIP/NSP and 
years of experience in area of practice before undertaking the prescribing course are 
presented in Table 1.  
Specialist qualification 
Two hundred and twenty four (55%) had undertaken diploma, degree and or masters 
modules in diabetes. One hundred and eighty nine (46%) had attended accredited 
study days. Ninety four (23%) had undergone informal training. This included visits 
to a specialist nurse or doctor working in a diabetes department, in-house training, and 
training provided by drug companies. Eighty two (20%) had not undertaken any 
specialist training in diabetes. 
 
Methods used to deliver medicines 
Four hundred and nine (93.1%) participants reported that they used independent 
prescribing and 214 (49.8%) used supplementary prescribing. Two hundred and 
twenty (51.2%) respondents used Patient Group Directions (PGDs) (i.e. a direction to 
a nurse to supply and/or administer a medicine to a group of patients) and 43 (10.0%) 
used Patient Specific Directions (PSDs) (i.e. a direction from a registered prescriber to 
a nurse to administer a medicine to a named patient). 
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To what extent did the prescribing programme meet your needs with regards to 
the principles necessary for prescribing in diabetes? 
Figure 1 shows (by percentages responding) the extent to which the prescribing 
programme met the respondents’ needs with regards to the principles necessary for 
prescribing for people with diabetes.  Levels of satisfaction and dissatisfaction appear 
to be balanced with about half being biased in the direction of “did not meet needs” 
and half in the direction of “met needs completely”. 
 INSERT FIGURE 1 HERE 
One hundred and seventy eight participants ( 54%) of those who had had specialist 
training felt their needs with regard to principles necessary for prescribing for people 
with diabetes had been met compared with just  seventeen (21%)  amongst those who 
had not had specialist training.  Using the Chi square test the difference in these 
percentages was statistically significant (p<0.001) (see Table 2).  However, there was 
insufficient evidence of a difference in percentages reporting their needs were met 
across different levels of academic qualifications (p=0.339) (see Table 3).  
INSERT TABLE 2 & 3 HERE 
 
 
How useful was the 12 days medical practice support that you received during 
the prescribing programme in meeting your needs to prescribe for patients with 
diabetes? 
Figure 2 shows (by percentage responding) the extent to which the 12 days medical 
practice support received during the prescribing programme was useful in meeting 
needs to prescribe for patients with diabetes.  Levels of satisfaction and dissatisfaction 
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were balanced with about half being biased in the direction of ‘useful’ and ‘not at all 
useful’. 
INSERT FIGURE 2 HERE 
The results  of  the chi squared test indicated strong evidence (p=0.<0.001) that one 
hundred and seventy seven respondents (54%) with specialist training in diabetes felt 
that the 12 days medical practice support they received was useful compared to 
twenty five(31%) without specialist training (see Table 4). There was no evidence of a 
difference with regards to respondents’ academic qualifications (p=0.121) (See Table 
5).  
INSERT Table 4 & 5 HERE 
 
Did you spend some of these 12 days with another qualified NIP/NSP?  
About 30% of respondents reported that they had spent some of the above 12 days 
with another qualified NIP/NSP.  About 17% had spent more than 3 days with a 
NIP/NSP, while about 35% had spent less than 2 days with a NIP/NSP.  The average 
number of days spent with another NIP/NSP was about 2.5 days (standard error = 
0.195).   
.  
Views on prescribing for people with diabetes 
Seventy five percent of respondents (316) selected the two highest rating i.e. 
indicating that patient access to medicines was faster. Seven percent (31) selected the 
two lowest. The mean was 5.0 (std. error 0.065). With respect to quality of care 
offered to diabetic patients, 66% (281) of respondents selected the two highest ratings 
indicating that this had improved. Eight percent (33) selected the two lowest. The 
mean was 4.8 (std. error 0.067).   
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Eighty one per cent (342) of respondents selected the two highest ratings with regards 
to use of skills and job satisfaction i.e. they agreed that this had improved through 
prescribing.  Five percent (22) selected the two lowest. The mean was 5.2 (std. error 
0.057).  
 
Success of the prescribing programme 
Using a general linear model, it was evident that participants with specialist 
qualifications in diabetes had a  significantly higher score  (5.1 on average), on the 
success of the prescribing programme compared to an average score of 4.5 for those 
without specialist qualifications (p=0.001).   
 
DISCUSSION 
 
A potential limitation of our study is that we did not ask respondents which methods 
they had used to deliver medicines to patients within the last 6 months i.e. they were 
asked to report on the methods used since qualifying. The majority of respondents had 
been qualified in excess of 2 years and methods used within the last 6 months may 
have differed from those used upon initial qualification. For example, the experience 
of the prescriber may have influenced methods used. This additional data would have 
provided a fuller picture of current practice.  
 
The majority of nurses in our sample held an academic qualification at degree level or 
higher, had a wealth of clinical experience, work full-time, were based in primary care 
and worked in general practice. Nearly 50% of respondents had used supplementary 
prescribing for patients with diabetes and nearly all participants reported that they had 
prescribed independently for these patients.  
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These findings are consistent with the findings from national surveys reported by 
Latter et al. (2005) and Courtenay et al. (2006a). Over 80% of both the 246 
independent extended prescribers in Latter et al.’s survey, and the 868 independent 
extended/supplementary prescribers, surveyed by Courtenay et al., reported that they 
held a degree or masters level qualification, and worked in primary care. As in our 
study, the majority of participants in Courtenay et al.’s study also had far beyond the 
3years post registration experience required in order to access the prescribing course 
(NMC 2006)  i.e. these researchers reported that 88% of their sample had more than 
10 years experience as a qualified nurse. 
 
The number of nurses in our study using independent prescribing is also consistent 
with those reported by Courtenay et al. (2006b). Ninety five percent of the 638 nurses 
these researchers surveyed used independent prescribing for skin conditions. 
However, only 37% used supplementary prescribing i.e. 13% less than that reported 
by participants in our study.  The fact that our findings show that quite a high 
percentage of nurses are using supplementary prescribing, despite the fact that nurses 
are now able to independently prescribe practically any licensed medicine, 
demonstrates that there is still a need for Nurse Supplementary Prescribing in the care 
of people with diabetes. This could be because some nurses, when caring for complex 
patients with diabetes (such as those with micro and macro vascular complications), 
prefer to do so in partnership with a doctor. This requires further exploration 
 
Levels of satisfaction and dissatisfaction with the prescribing programme and the 12 
days medical practice support were balanced with about 50% biased in the direction 
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of ‘did not meet needs’ and half in the direction of ‘completely met my needs. This is 
in contrast to the findings reported by Latter et al. (2005) and Courtenay et al. 
(2006b). Over half the respondents in these studies reported that the taught element of 
the prescribing programme met their needs to some extent, and they were either 
satisfied or very satisfied with the support received during the 12 days in practice. 
This finding requires further exploration. Thirty percent of our sample reported that 
they received additional support during the 12 days in practice from other NIPs/NSPs. 
This is in line with policy literature. Although a medical practitioner is responsible for 
the education and assessment of students on the prescribing programme, a buddy 
system is recommended whereby it is expected that students on the course will utilise 
support from other healthcare professionals during the 12 days in practice (DoH 
2002).  
 
Only 20% of our sample reported that they had not undertaken any specialist training 
in diabetes (i.e. a diploma, degree, or master’s level module in diabetes or, accredited 
study days). Our results showed that nurses with this training found that the 
prescribing programme and the 12 days learning in practice met their needs to a 
significantly greater extent than those without. These findings are in line with those 
reported by Courtenay et al. (2006b). These researchers reported that participants in 
their study, who had undertaken specialist training in dermatology prior to the 
prescribing programme, indicated that both the taught element of the course and the 
12 days learning in practice met their needs to prescribe for these conditions to a 
significantly greater extent than those who had not undertaken this training.   
 
 21 
The prescribing programme teaches nurses the principles underpinning prescribing 
practice. It is not designed to provide nurses with specialist knowledge and skills  
(NMC 2006). The need for nurses to acquire specialist knowledge prior to 
undertaking the programme is reinforced by our findings.  
 
It is evident from our findings that participants view prescribing positively i.e. they 
agree that it enables faster access to medicines, better use of nurses’ skills, improves 
job satisfaction, and improves the quality of care for patients with diabetes. These 
findings are in line with Latter et al. 2005. Over 90% of the 246 participants sampled 
by these researchers strongly agreed or agreed that prescribing had also achieved each 
of these components. This is in line with Government prescribing policy, the aims of 
which are to make it easier for patients to get their medicines, increase choice with 
regards to access, and make better use of nursing skills (DoH 2005).  
 
CONCLUSION  
Although nurse prescribing has effectively increased patient choice with regards to 
accessing medicines for diabetes, approximately 50% of the nurses in this study 
reported that the prescribing programme did not meet their needs for this role. The 
needs of nurses with specialist training in diabetes were met to a greater extent than 
those without this training. Twenty percent of the nurses in this study did not have this 
training.  The educational preparation for nurses adopting the role of prescriber for 
people with diabetes requires further exploration.  Although the role nurses play in the 
prescription of medicines differs worldwide, our study may be of interest, and have 
implications, for those responsible for the education and preparation of nurses 
working in the area of diabetes.  
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Tables and Figures 
Table 1: Demographic characteristics 
 
 
 
             n=number of 
responses 
% of total 
sample 
Job Title  
General practice   
(practice nurses and nurse practitioners) 
275 62.8 
Specialist nurses   
(clinical nurse specialists, specialist nurse practitioners, nurse 
clinicians, children’s nurses and midwives) 
77 17.6 
Community Nurses  
(community/modern matron, HV, DN, community children’s nurse 
specialist, community psychiatric nurses and learning disabilities) 
63 14.4 
Senior Nurses  
(nurse consultants, senior nurses, charge nurses, sisters, manager) 
23 5.3 
Grade/Band  
Grade E or Band 5 2 0.5 
Grade F/G or Band 6 115 26.7 
Grade H or Band 7 195 44.4 
Grade I or Band 8/9 or Nurse Partner  104 23.7 
Part time/full time  
<20 hrs per week 39 6.9 
21-30 per week 142 32.6 
Full time i.e. >30 hrs per week 264 60 
Primary/and or Secondary Care  
Primary care 369 84.2 
Secondary Care 43 9.8 
Primary and Secondary Care 26 5.9 
Age   
<35 years  28 6.4 
36-45 years 171 39 
46-55 years 191 43.6 
55-65 years 48 11 
Academic Qualification   
Certificate level 16 3.6 
Diploma level 66 15 
Degree level 247 56.3 
Master level 110 25.1 
Time since Qualified as NIP/NSP   
< 6 months 13 3 
6-12 months 56 12.9 
1-2 years 146 34.2 
> 2 years 213 49.9 
Experience in area of practice before NIP/NSP   
< 1 year 10 2.4 
1-2 years 28 6.6 
2-5 years 69 16.2 
> 5 years 318 74.8 
Percents do not add to 100%  in each category as some participants 
 did not complete every question 
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Figure 1.  Extent to which the prescribing 
programme met needs with regards to the 
principles necessary for prescribing in diabetes
Did not meet needs
Met needs completely
0 5 10 15 20 25 30
Percent of respondents
 
 
Table 2   The effect of specialist training in diabetes on the extent to which the principles of 
diabetes prescribing were met 
 
 
Specialist training in diabetes 
Total 
n=409 
No Yes 
n % n % 
Needs not met 65 30.4 149 69.7 214 
Met needs completely 17 8.7 178 91.3 195 
 
 
 
 
 
 
 
Table 3  The effect of academic qualification on the extent to which the principles of diabetes 
prescribing were met 
  
  Highest academic qualification  
  
Certificate/ 
Diploma Degree Masters/Phd Total  
Needs not met Count 40 127 47 214 
  % 51.3% 55.2% 46.5% 52.3% 
Met needs completely Count 38 103 54 195 
  % 48.7% 44.8% 53.5% 47.7% 
Total Count 78 230 101 409 
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 % 100.0% 100.0% 100.0% 100.0% 
 
 
Figure 2.  Extent to which the 12 days medical 
practice support received was useful
Not useful at all
Very Useful
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Percent of respondents
 
 
Table 4.  Value of medical practice support in meeting diabetes prescribing needs across 
whether or not respondent had had specialist training in diabetes 
 
Value of medical 
practice support 
 Specialist training in diabetes  
 No Yes Total 
Not useful Count 57 149 206 
  % 69.5% 45.7% 50.5% 
Useful Count 25 177 202 
  % 30.5% 54.3% 49.5% 
Total Count 82 326 408 
 % 100.0% 100.0% 100.0% 
 
 
Table 5. Value of medical practice support in meeting diabetes prescribing needs across 
academic qualifications 
 
Value of medical 
practice support 
  Highest academic qualification  
  
Certificate/ 
Diploma Degree Masters/Phd Total  
Not useful Count 37 126 43 206 
  % 47.4% 54.8% 43.0% 50.5% 
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Useful Count 41 104 57 202 
  % 52.6% 45.2% 57.0% 49.5% 
Total Count 78 230 100 408 
 % 100.0% 100.0% 100.0% 100.0% 
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